Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Keech

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Pharmacoeconomics|February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UKJunwen Zhou, Runguo Wu, Claire Williams, et al.
Journal of the American Society of Nephrology : JASN|October 28, 2005
Effect of pravastatin in people with diabetes and chronic kidney diseaseMarcello Tonelli, Anthony Keech, Jim Shepherd, et al.
Journal of the American College of Cardiology|February 5, 2025
Long-Term Lipid Lowering With Evolocumab in Older IndividualsSamer Al Said, Michelle L O'Donoghue, Xinhui Ran, et al.
Plos One|April 11, 2022
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumabLaura E Korthauer, Robert P Giugliano, Jianping Guo, et al.
Health Technology Assessment (Winchester, England)|December 7, 2024
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data setsBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
The Lancet Regional Health. Europe|March 29, 2024
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Heart (British Cardiac Society)|September 10, 2024
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Journal of the American College of Cardiology|March 18, 2022
Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMIChristopher C Y Wong, Andy S C Yong, Anthony Keech, et al.
Circulation|March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?R John Simes, Ian C Marschner, David Hunt, et al.
Heart, Lung & Circulation|July 6, 2021
Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison StudyKaran K Shah, Daniel Elder, Mai T H Nguyen, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Pharmacoeconomics|February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UKJunwen Zhou, Runguo Wu, Claire Williams, et al.
Journal of the American Society of Nephrology : JASN|October 28, 2005
Effect of pravastatin in people with diabetes and chronic kidney diseaseMarcello Tonelli, Anthony Keech, Jim Shepherd, et al.
Journal of the American College of Cardiology|February 5, 2025
Long-Term Lipid Lowering With Evolocumab in Older IndividualsSamer Al Said, Michelle L O'Donoghue, Xinhui Ran, et al.
Plos One|April 11, 2022
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumabLaura E Korthauer, Robert P Giugliano, Jianping Guo, et al.
Health Technology Assessment (Winchester, England)|December 7, 2024
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data setsBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
The Lancet Regional Health. Europe|March 29, 2024
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Heart (British Cardiac Society)|September 10, 2024
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Journal of the American College of Cardiology|March 18, 2022
Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMIChristopher C Y Wong, Andy S C Yong, Anthony Keech, et al.
Circulation|March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?R John Simes, Ian C Marschner, David Hunt, et al.
Heart, Lung & Circulation|July 6, 2021
Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison StudyKaran K Shah, Daniel Elder, Mai T H Nguyen, et al.
Pageof 10